Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

187 Mon, 7/31/2017, 12:30 PM - 1:50 PM CC-Ballroom II
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Qi Jiang, Amgen Inc.
ML09: Applying Bayesian Methodology to Precision Medicine Judy X. Li, Regeneron Pharmaceuticals
ML10: FDA Draft Guidance on Multiple Endpoints Kate Liu, Amgen, Inc.
ML11: How to Treat Site in Clinical Trials - Fixed or Random? Chul Ahn, FDA
ML12: How We Take Advantage of Big Data When Dealing with the Dilemma in Early-Phase Oncology? Shaoyi Li, Celgene
ML13: Non-Inferiority Trials for Efficacy and Safety Steve Snapinn, Amgen
Copyright © American Statistical Association